Condition
Moderate to Severe Asthma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Moderate to Severe Asthma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), China (3)). By phase: Phase 4 (2), Phase 2/3 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Moderate to Severe Asthma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pulmonary Neuromodulation for Asthma Relief in Moderate to Severe Asthma | — | Denver, Colorado and 2 other locations | Recruiting | Jul 17, 2026 |
| RC1416 shots for moderate to severe asthma | Phase 2 | Anqing, Anhui and 43 other locations | Recruiting | Feb 11, 2026 |
| CM326 for adults with moderate to severe asthma | Phase 3 | Shanghai, Shanghai Municipality | Recruiting | Jan 28, 2026 |
| Bringing SMART inhaler therapy to community health clinics | Phase 4 | St Louis, Missouri and 6 other locations | Recruiting | Nov 21, 2025 |
| Using genetics to improve asthma treatment | Phase 4 | Scottsdale, Arizona and 2 other locations | Recruiting | Apr 26, 2024 |
| Evaluating CM310 for treating moderate to severe asthma | Phase 2/3 | Beijing, Beijin | Recruiting | Mar 9, 2023 |
All recruiting trials (6)
-
Pulmonary Neuromodulation for Asthma Relief in Moderate to Severe Asthma
This trial tests pulmonary neuromodulation using spinal cord stimulation in adults with uncontrolled moderate to severe asthma to see if it can help improve symptoms.
-
RC1416 shots for moderate to severe asthma
This study tests RC1416 versus placebo to see if it helps adults with severe uncontrolled asthma stay out of flare-ups and breathe better.
-
CM326 for adults with moderate to severe asthma
This 52-week, double-blind, placebo-controlled study will test whether CM326 helps adults (ages 18–80) with moderate to severe asthma who are already on medium-to-high dose inhaled corticosteroids and other controller medicines.
-
Bringing SMART inhaler therapy to community health clinics
This project will test a program that helps community clinic clinicians start using SMART inhaler treatment for adults with moderate to severe asthma.
-
Using genetics to improve asthma treatment
This study is testing how well two asthma treatments work for people with moderate to severe asthma by looking at their genetic information to see who might benefit the most.
-
Evaluating CM310 for treating moderate to severe asthma
This study is testing a new drug called CM310 to see if it can help people with moderate to severe asthma breathe better and feel more comfortable.
Quick answers
How many Moderate to Severe Asthma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), China (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2/3: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.